H
ashimoto encephalopathy (HE) is defined by spontaneous subacute encephalopathy with raised thyroid autoantibodies and a remarkable responsiveness to steroids. 1, 2 Pathophysiologically, an association with Hashimoto thyroiditis is characterized by observations of elevated thyroid peroxidase antibody (TPO-Ab) levels or thyroglobulin antibody (TG-Ab) levels. 3, 4 We describe a patient who developed HE following iodine 131 ( 131 I) radiotherapy of Graves disease.
Report of a Case. In February 2005, a 61-year-old man with a 6-year history of Graves disease was admitted to hospital for 131 I radiotherapy. Thyroid function measures were as follow: thyroid-stimulating hormone (TSH) level, 0.29 µU/mL (reference, 0.35-4.5 µU/mL); free thyroxine (FT 4 ) level, 17.1 pg/mL (reference, 8.0-18 pg/ mL); free triiodothyronine (FT 3 ) level, 3.6 ng/L (reference, 1.8-4.6 ng/L); and TSH-receptor antibody level, 1.6 mU/L (reference, Ͻ1 mU/L). Tests for TG-Ab were negative, and TPO-Ab levels were elevated (Ͼ1000 U/mL; reference, Ͻ35 U/mL). Apart from a slightly enlarged thyroid and exophthalmos, physical examination findings were normal. After 131 I radiotherapy, the patient developed mild asymptomatic hypothyroidism, and therefore substitution therapy with levothyroxine 50 µg daily was initiated.
In mmol/L (reference, 0.7-2.9 mmol/L). Tests for TSHreceptor antibodies and TG-Ab were negative. Levels of TPO antibodies (Ͼ1000 U/mL, reference, Ͻ35 U/mL) were elevated. Figure) . Corticosteroid therapy was started with initially 100-mg prednisolone per day. During the following weeks, the patient improved dramatically concerning neurological examination findings, alertness, psychomotor behavior, memory, speech, and mood. In accordance with this, an MRI scan in January 2007 documented an almost complete resolution of the frontal and temporal lesions (Figure) . The constellation of raised thyroid autoantibody levels; the typical diffuse, nonenhancing white matter lesions; and the raised lymphocyte count and protein level of the sterile CSF suggested the diagnosis of HE that might be accompanied by 14-3-3 protein and oligoclonal bands. 5 In particular, the striking therapeutic response to steroids, including normalization of the electroencephalogram and the MRI abnormalities that had spared the basal ganglia, further supported the diagnosis of HE especially regarding the differential diagnosis of CreutzfeldtJakob disease.
Comment. To our knowledge, this is the first report of HE following 131 I radiotherapy. In 4 reports, an encephalopathy was already observed in the course of Graves disease 6 but without preceding 131 I radiotherapy. In the present report, because of the clear temporal correlation between 131 I radiotherapy and the onset of the encephalopathy 4 weeks later, the possibility of a causal relationship between thyroid tissue destruction and the development of HE is strengthened. The fact that TPO-Ab levels were elevated already before 131 I radiotherapy weakened their etiological role in HE so that additional thyroid antigens released after 131 I radiotherapy or during a spontaneous occurrence of Hashimoto thyroiditis might be responsible for the immune attack against the central nervous system. This case report suggests that next to Hashimoto thyroiditis, a second thyroid pathology going ahead with tissue destruction might now be identified to potentially cause a treatable encephalopathy like HE. Thus, the mechanisms that lead to HE might not strictly depend on the character of the initial thyroid damage. 
